[ad_1] Nektar Therapeutics (NASDAQ: NKTR) offers a good deal with a P / S ratio of 25.52. The broad biotech industry has an average P / S ratio of 251.09, which is …
Read More »A confrontation of evaluation? – Nektar Therapeutics (NKTR), Fortive Corporation (FTV)
